Citadel Advisors
ERAS icon

Citadel Advisors’s Erasca ERAS Stock Holding History

Citadel Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.67M Buy
226,900
+124,500
+122% +$1.47M ﹤0.01% 4871
2025
Q4 		$381K Buy
102,400
+47,600
+87% +$134K ﹤0.01% 9642
2025
Q3 		$119K Buy
54,800
+29,600
+117% +$47.1K ﹤0.01% 11713
2025
Q2 		$32K Buy
25,200
+4,600
+22% +$6.16K ﹤0.01% 11960
2025
Q1 		$28.2K Buy
20,600
+9,700
+89% +$16.6K ﹤0.01% 12877
2024
Q4 		$27.4K Buy
10,900
+800
+8% +$2.19K ﹤0.01% 12954
2024
Q3 		$27.6K Buy
10,100
+7,000
+226% +$19.7K ﹤0.01% 12510
2024
Q2 		$7.32K Sell
3,100
-4,000
-56% -$8.63K ﹤0.01% 13258
2024
Q1 		$14.6K Buy
7,100
+2,700
+61% +$5.4K ﹤0.01% 13228
2023
Q4 		$9.37K Buy
4,400
+4,000
+1,000% +$8.44K ﹤0.01% 13156
2023
Q3 		$788 Buy
400
+200
+100% +$512 ﹤0.01% 13981
2023
Q2 		$552 Sell
200
-2,600
-93% -$7.41K ﹤0.01% 14089
2023
Q1 		$8.43K Buy
2,800
+1,000
+56% +$3.64K ﹤0.01% 13661
2022
Q4 		$7.76K Buy
+1,800
New +$12.2K ﹤0.01% 13799

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Citadel Advisors's ERAS Position: Q1 2026 in Review

Citadel Advisors reduced its Erasca (ERAS) stake by 52% in Q1 2026, selling an estimated $6.29M and leaving 498,381 shares worth $8.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Citadel Advisors first reported a position in ERAS in Q3 2021 and has held it in 17 quarters since. The position peaked at $11.8M in Q3 2024. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Citadel Advisors held 498,381 shares of Erasca worth $8.06M as of Q1 2026.
  • Citadel Advisors sold 531,964 Erasca shares in Q1 2026, an estimated $6.29M.
  • Erasca made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3569 holding.
  • Citadel Advisors first reported a position in Erasca in Q3 2021 and has held it in 17 quarters since.
  • Citadel Advisors's Erasca position peaked at $11.8M in Q3 2024.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.